Dr. Barry Dworkin

Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can’t do it.

Medical Mythbusting Commentary for February 3, 2021

Source:
Myths of Vaccine Manufacturing
A vial, a vaccine and hopes for slowing a pandemic — how a shot comes to be
Why Even Presidential Pressure Might Not Get More Vaccine to Market Faster

Reference:
Exploring the Supply Chain of the Pfizer/BioNTech and Moderna COVID-19 vaccines

Related posts:

  1. New biotherapeutic cancer treatment centre an excellent addition to novel therapeutic solutions
  2. New Ottawa immunotherapy company proposes to develop new treatments for cancer
  3. The development of mRNA vaccine technology has the potential to expand to treat and prevent other diseases akin to the technological spinoffs seen with the Apollo space program.
  4. Logistics of distributing mRNA vaccines (if approved) will be problematic. Excellent article in @TheAtlantic explains why.